LOS ANGELES CAPITAL MANAGEMENT LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$685,000
+178.5%
8,061
-55.9%
0.00%
+50.0%
Q1 2020$246,000
-6.5%
18,285
+47.0%
0.00%
+100.0%
Q4 2019$263,000
+49.4%
12,443
-6.1%
0.00%0.0%
Q3 2019$176,000
-74.8%
13,253
-73.7%
0.00%
-75.0%
Q2 2019$699,000
+16.3%
50,420
+61.2%
0.00%
+33.3%
Q1 2019$601,00031,2800.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders